nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—POMC—coronary artery disease	0.248	0.64	CbGaD
Loperamide—OPRD1—coronary artery disease	0.14	0.36	CbGaD
Loperamide—CYP2C8—Fenofibrate—coronary artery disease	0.0193	0.0547	CbGbCtD
Loperamide—CYP2B6—Clopidogrel—coronary artery disease	0.0177	0.05	CbGbCtD
Loperamide—CYP2C8—Gemfibrozil—coronary artery disease	0.0154	0.0437	CbGbCtD
Loperamide—ABCB1—Ticagrelor—coronary artery disease	0.0146	0.0415	CbGbCtD
Loperamide—CYP2C8—Clopidogrel—coronary artery disease	0.0134	0.0379	CbGbCtD
Loperamide—CYP2C8—Pitavastatin—coronary artery disease	0.0117	0.0331	CbGbCtD
Loperamide—CYP2B6—Simvastatin—coronary artery disease	0.0106	0.03	CbGbCtD
Loperamide—CYP2B6—Atorvastatin—coronary artery disease	0.00943	0.0267	CbGbCtD
Loperamide—ABCB1—Clopidogrel—coronary artery disease	0.00905	0.0257	CbGbCtD
Loperamide—ABCB1—Perindopril—coronary artery disease	0.00905	0.0257	CbGbCtD
Loperamide—CYP3A4—Ticagrelor—coronary artery disease	0.00878	0.0249	CbGbCtD
Loperamide—POMC—sympathetic nervous system—coronary artery disease	0.00852	0.207	CbGeAlD
Loperamide—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.0084	0.0238	CbGbCtD
Loperamide—POMC—vagus nerve—coronary artery disease	0.00825	0.2	CbGeAlD
Loperamide—CYP2C8—Simvastatin—coronary artery disease	0.00801	0.0227	CbGbCtD
Loperamide—ABCB1—Pitavastatin—coronary artery disease	0.00791	0.0224	CbGbCtD
Loperamide—ABCB1—Telmisartan—coronary artery disease	0.00791	0.0224	CbGbCtD
Loperamide—CYP2C8—Lovastatin—coronary artery disease	0.00784	0.0222	CbGbCtD
Loperamide—CYP2C8—Pravastatin—coronary artery disease	0.00784	0.0222	CbGbCtD
Loperamide—CYP3A4—Fenofibrate—coronary artery disease	0.00782	0.0222	CbGbCtD
Loperamide—ABCB1—Enalapril—coronary artery disease	0.0075	0.0213	CbGbCtD
Loperamide—ABCB1—Lisinopril—coronary artery disease	0.0075	0.0213	CbGbCtD
Loperamide—CYP2C8—Atorvastatin—coronary artery disease	0.00714	0.0202	CbGbCtD
Loperamide—CYP2C8—Losartan—coronary artery disease	0.00653	0.0185	CbGbCtD
Loperamide—CYP2D6—Niacin—coronary artery disease	0.00646	0.0183	CbGbCtD
Loperamide—ABCB1—Timolol—coronary artery disease	0.00638	0.0181	CbGbCtD
Loperamide—CYP3A4—Gemfibrozil—coronary artery disease	0.00625	0.0177	CbGbCtD
Loperamide—CYP2D6—Timolol—coronary artery disease	0.00601	0.017	CbGbCtD
Loperamide—ABCB1—Ezetimibe—coronary artery disease	0.00583	0.0165	CbGbCtD
Loperamide—POMC—autonomic nervous system—coronary artery disease	0.00573	0.139	CbGeAlD
Loperamide—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00568	0.0161	CbGbCtD
Loperamide—ABCB1—Captopril—coronary artery disease	0.00561	0.0159	CbGbCtD
Loperamide—CYP3A4—Clopidogrel—coronary artery disease	0.00542	0.0154	CbGbCtD
Loperamide—ABCB1—Simvastatin—coronary artery disease	0.00542	0.0154	CbGbCtD
Loperamide—ABCB1—Lovastatin—coronary artery disease	0.00531	0.015	CbGbCtD
Loperamide—ABCB1—Pravastatin—coronary artery disease	0.00531	0.015	CbGbCtD
Loperamide—CYP2D6—Captopril—coronary artery disease	0.00529	0.015	CbGbCtD
Loperamide—CYP2D6—Simvastatin—coronary artery disease	0.00511	0.0145	CbGbCtD
Loperamide—CYP3A4—Eplerenone—coronary artery disease	0.00504	0.0143	CbGbCtD
Loperamide—CYP2D6—Pravastatin—coronary artery disease	0.005	0.0142	CbGbCtD
Loperamide—CYP2D6—Lovastatin—coronary artery disease	0.005	0.0142	CbGbCtD
Loperamide—ABCB1—Atorvastatin—coronary artery disease	0.00483	0.0137	CbGbCtD
Loperamide—CYP2D6—Atorvastatin—coronary artery disease	0.00455	0.0129	CbGbCtD
Loperamide—CYP3A4—Enalapril—coronary artery disease	0.00449	0.0127	CbGbCtD
Loperamide—ABCB1—Losartan—coronary artery disease	0.00442	0.0125	CbGbCtD
Loperamide—CYP3A4—Rosuvastatin—coronary artery disease	0.00349	0.0099	CbGbCtD
Loperamide—CYP3A4—Ezetimibe—coronary artery disease	0.00349	0.0099	CbGbCtD
Loperamide—CYP3A4—Simvastatin—coronary artery disease	0.00325	0.00921	CbGbCtD
Loperamide—CYP3A4—Pravastatin—coronary artery disease	0.00318	0.00901	CbGbCtD
Loperamide—CYP3A4—Lovastatin—coronary artery disease	0.00318	0.00901	CbGbCtD
Loperamide—CYP3A4—Atorvastatin—coronary artery disease	0.0029	0.00821	CbGbCtD
Loperamide—CYP3A4—Losartan—coronary artery disease	0.00265	0.00751	CbGbCtD
Loperamide—CALM1—sympathetic nervous system—coronary artery disease	0.00232	0.0562	CbGeAlD
Loperamide—CALM1—autonomic nervous system—coronary artery disease	0.00156	0.0378	CbGeAlD
Loperamide—POMC—heart—coronary artery disease	0.0012	0.029	CbGeAlD
Loperamide—POMC—cardiovascular system—coronary artery disease	0.00113	0.0274	CbGeAlD
Loperamide—POMC—blood—coronary artery disease	0.000893	0.0217	CbGeAlD
Loperamide—CALM2—artery—coronary artery disease	0.000887	0.0215	CbGeAlD
Loperamide—CALM1—artery—coronary artery disease	0.000883	0.0214	CbGeAlD
Loperamide—CALM2—endothelium—coronary artery disease	0.000749	0.0182	CbGeAlD
Loperamide—CALM1—endothelium—coronary artery disease	0.000746	0.0181	CbGeAlD
Loperamide—CALM3—cardiac ventricle—coronary artery disease	0.000634	0.0154	CbGeAlD
Loperamide—CALM3—myocardium—coronary artery disease	0.000596	0.0145	CbGeAlD
Loperamide—CALM2—cardiac ventricle—coronary artery disease	0.000498	0.0121	CbGeAlD
Loperamide—CALM1—cardiac ventricle—coronary artery disease	0.000495	0.012	CbGeAlD
Loperamide—CALM2—myocardium—coronary artery disease	0.000468	0.0114	CbGeAlD
Loperamide—CALM1—myocardium—coronary artery disease	0.000466	0.0113	CbGeAlD
Loperamide—CALM3—heart—coronary artery disease	0.000416	0.0101	CbGeAlD
Loperamide—Diphenoxylate—OPRD1—coronary artery disease	0.000393	0.22	CrCbGaD
Loperamide—CALM3—cardiac atrium—coronary artery disease	0.000356	0.00863	CbGeAlD
Loperamide—Tamoxifen—SULT1A1—coronary artery disease	0.000336	0.188	CrCbGaD
Loperamide—OPRM1—blood—coronary artery disease	0.000336	0.00815	CbGeAlD
Loperamide—CALM2—heart—coronary artery disease	0.000327	0.00793	CbGeAlD
Loperamide—CALM1—heart—coronary artery disease	0.000325	0.00789	CbGeAlD
Loperamide—CALM3—blood—coronary artery disease	0.00031	0.00753	CbGeAlD
Loperamide—CALM2—cardiovascular system—coronary artery disease	0.000308	0.00748	CbGeAlD
Loperamide—CALM1—cardiovascular system—coronary artery disease	0.000307	0.00744	CbGeAlD
Loperamide—CALM2—cardiac atrium—coronary artery disease	0.000279	0.00678	CbGeAlD
Loperamide—CALM1—cardiac atrium—coronary artery disease	0.000278	0.00675	CbGeAlD
Loperamide—CALM2—blood—coronary artery disease	0.000244	0.00591	CbGeAlD
Loperamide—CYP2B6—heart—coronary artery disease	0.000243	0.00589	CbGeAlD
Loperamide—CALM1—blood—coronary artery disease	0.000243	0.00589	CbGeAlD
Loperamide—CYP2B6—cardiovascular system—coronary artery disease	0.000229	0.00556	CbGeAlD
Loperamide—CYP2C8—blood—coronary artery disease	0.000202	0.0049	CbGeAlD
Loperamide—CYP2B6—blood—coronary artery disease	0.000181	0.0044	CbGeAlD
Loperamide—Dextropropoxyphene—OPRD1—coronary artery disease	0.000171	0.0958	CrCbGaD
Loperamide—Fentanyl—OPRD1—coronary artery disease	0.000169	0.0948	CrCbGaD
Loperamide—Toremifene—ESR1—coronary artery disease	0.000146	0.0817	CrCbGaD
Loperamide—CYP3A4—blood—coronary artery disease	0.000137	0.00332	CbGeAlD
Loperamide—CYP2D6—blood—coronary artery disease	0.000135	0.00327	CbGeAlD
Loperamide—ABCB1—heart—coronary artery disease	0.00013	0.00315	CbGeAlD
Loperamide—ABCB1—cardiovascular system—coronary artery disease	0.000123	0.00297	CbGeAlD
Loperamide—Methadone—OPRD1—coronary artery disease	0.000116	0.065	CrCbGaD
Loperamide—Gastrointestinal pain—Enalapril—coronary artery disease	0.000108	0.00109	CcSEcCtD
Loperamide—Abdominal pain—Pravastatin—coronary artery disease	0.000107	0.00109	CcSEcCtD
Loperamide—Dizziness—Clopidogrel—coronary artery disease	0.000107	0.00108	CcSEcCtD
Loperamide—Pruritus—Simvastatin—coronary artery disease	0.000106	0.00108	CcSEcCtD
Loperamide—Dizziness—Lovastatin—coronary artery disease	0.000106	0.00108	CcSEcCtD
Loperamide—Loss of consciousness—Ramipril—coronary artery disease	0.000106	0.00108	CcSEcCtD
Loperamide—Gastrointestinal pain—Telmisartan—coronary artery disease	0.000106	0.00108	CcSEcCtD
Loperamide—Somnolence—Furosemide—coronary artery disease	0.000106	0.00107	CcSEcCtD
Loperamide—Gastrointestinal disorder—Perindopril—coronary artery disease	0.000106	0.00107	CcSEcCtD
Loperamide—Diarrhoea—Eplerenone—coronary artery disease	0.000106	0.00107	CcSEcCtD
Loperamide—Fatigue—Perindopril—coronary artery disease	0.000106	0.00107	CcSEcCtD
Loperamide—Urticaria—Trandolapril—coronary artery disease	0.000105	0.00106	CcSEcCtD
Loperamide—Constipation—Perindopril—coronary artery disease	0.000105	0.00106	CcSEcCtD
Loperamide—Vomiting—Fenofibrate—coronary artery disease	0.000105	0.00106	CcSEcCtD
Loperamide—Hypersensitivity—Valsartan—coronary artery disease	0.000105	0.00106	CcSEcCtD
Loperamide—Urticaria—Enalapril—coronary artery disease	0.000104	0.00106	CcSEcCtD
Loperamide—Abdominal pain—Trandolapril—coronary artery disease	0.000104	0.00106	CcSEcCtD
Loperamide—Dizziness—Ezetimibe—coronary artery disease	0.000104	0.00106	CcSEcCtD
Loperamide—Abdominal pain—Enalapril—coronary artery disease	0.000104	0.00105	CcSEcCtD
Loperamide—Rash—Fenofibrate—coronary artery disease	0.000104	0.00105	CcSEcCtD
Loperamide—Dermatitis—Fenofibrate—coronary artery disease	0.000104	0.00105	CcSEcCtD
Loperamide—Loss of consciousness—Timolol—coronary artery disease	0.000104	0.00105	CcSEcCtD
Loperamide—Headache—Fenofibrate—coronary artery disease	0.000103	0.00105	CcSEcCtD
Loperamide—Gastrointestinal pain—Captopril—coronary artery disease	0.000103	0.00105	CcSEcCtD
Loperamide—Urticaria—Telmisartan—coronary artery disease	0.000103	0.00104	CcSEcCtD
Loperamide—Vomiting—Clopidogrel—coronary artery disease	0.000103	0.00104	CcSEcCtD
Loperamide—Diarrhoea—Simvastatin—coronary artery disease	0.000103	0.00104	CcSEcCtD
Loperamide—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000103	0.00104	CcSEcCtD
Loperamide—Fatigue—Furosemide—coronary artery disease	0.000103	0.00104	CcSEcCtD
Loperamide—Abdominal pain—Telmisartan—coronary artery disease	0.000103	0.00104	CcSEcCtD
Loperamide—Vomiting—Lovastatin—coronary artery disease	0.000102	0.00104	CcSEcCtD
Loperamide—Somnolence—Losartan—coronary artery disease	0.000102	0.00104	CcSEcCtD
Loperamide—Dizziness—Eplerenone—coronary artery disease	0.000102	0.00103	CcSEcCtD
Loperamide—Rash—Clopidogrel—coronary artery disease	0.000102	0.00103	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000102	0.00103	CcSEcCtD
Loperamide—Dermatitis—Clopidogrel—coronary artery disease	0.000102	0.00103	CcSEcCtD
Loperamide—Asthenia—Valsartan—coronary artery disease	0.000102	0.00103	CcSEcCtD
Loperamide—Constipation—Furosemide—coronary artery disease	0.000102	0.00103	CcSEcCtD
Loperamide—Hypersensitivity—Niacin—coronary artery disease	0.000102	0.00103	CcSEcCtD
Loperamide—Discomfort—Ramipril—coronary artery disease	0.000102	0.00103	CcSEcCtD
Loperamide—Asthenia—Olmesartan—coronary artery disease	0.000101	0.00103	CcSEcCtD
Loperamide—Headache—Clopidogrel—coronary artery disease	0.000101	0.00103	CcSEcCtD
Loperamide—Rash—Lovastatin—coronary artery disease	0.000101	0.00103	CcSEcCtD
Loperamide—Dermatitis—Lovastatin—coronary artery disease	0.000101	0.00103	CcSEcCtD
Loperamide—Dyspepsia—Losartan—coronary artery disease	0.000101	0.00102	CcSEcCtD
Loperamide—Headache—Lovastatin—coronary artery disease	0.000101	0.00102	CcSEcCtD
Loperamide—Pruritus—Valsartan—coronary artery disease	0.0001	0.00102	CcSEcCtD
Loperamide—Dry mouth—Ramipril—coronary artery disease	0.0001	0.00102	CcSEcCtD
Loperamide—Vomiting—Ezetimibe—coronary artery disease	0.0001	0.00102	CcSEcCtD
Loperamide—Hypersensitivity—Pravastatin—coronary artery disease	0.0001	0.00102	CcSEcCtD
Loperamide—Gastrointestinal pain—Perindopril—coronary artery disease	0.0001	0.00102	CcSEcCtD
Loperamide—Angioedema—Lisinopril—coronary artery disease	0.0001	0.00101	CcSEcCtD
Loperamide—Pruritus—Olmesartan—coronary artery disease	0.0001	0.00101	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	9.98e-05	0.00101	CcSEcCtD
Loperamide—Abdominal pain—Captopril—coronary artery disease	9.97e-05	0.00101	CcSEcCtD
Loperamide—Dizziness—Simvastatin—coronary artery disease	9.95e-05	0.00101	CcSEcCtD
Loperamide—Rash—Ezetimibe—coronary artery disease	9.94e-05	0.00101	CcSEcCtD
Loperamide—Dermatitis—Ezetimibe—coronary artery disease	9.93e-05	0.00101	CcSEcCtD
Loperamide—Discomfort—Timolol—coronary artery disease	9.92e-05	0.00101	CcSEcCtD
Loperamide—Asthenia—Niacin—coronary artery disease	9.91e-05	0.001	CcSEcCtD
Loperamide—Fatigue—Losartan—coronary artery disease	9.9e-05	0.001	CcSEcCtD
Loperamide—Headache—Ezetimibe—coronary artery disease	9.88e-05	0.001	CcSEcCtD
Loperamide—Anaphylactic shock—Ramipril—coronary artery disease	9.85e-05	0.000998	CcSEcCtD
Loperamide—Dry mouth—Timolol—coronary artery disease	9.82e-05	0.000996	CcSEcCtD
Loperamide—Constipation—Losartan—coronary artery disease	9.82e-05	0.000996	CcSEcCtD
Loperamide—Vomiting—Eplerenone—coronary artery disease	9.81e-05	0.000995	CcSEcCtD
Loperamide—Nausea—Fenofibrate—coronary artery disease	9.78e-05	0.000991	CcSEcCtD
Loperamide—Pruritus—Niacin—coronary artery disease	9.77e-05	0.00099	CcSEcCtD
Loperamide—Asthenia—Pravastatin—coronary artery disease	9.76e-05	0.000989	CcSEcCtD
Loperamide—Gastrointestinal pain—Furosemide—coronary artery disease	9.73e-05	0.000987	CcSEcCtD
Loperamide—Rash—Eplerenone—coronary artery disease	9.73e-05	0.000986	CcSEcCtD
Loperamide—Urticaria—Perindopril—coronary artery disease	9.73e-05	0.000986	CcSEcCtD
Loperamide—Hypersensitivity—Trandolapril—coronary artery disease	9.73e-05	0.000986	CcSEcCtD
Loperamide—Dermatitis—Eplerenone—coronary artery disease	9.72e-05	0.000986	CcSEcCtD
Loperamide—Diarrhoea—Valsartan—coronary artery disease	9.72e-05	0.000985	CcSEcCtD
Loperamide—Hypersensitivity—Enalapril—coronary artery disease	9.69e-05	0.000982	CcSEcCtD
Loperamide—ABCB1—blood—coronary artery disease	9.69e-05	0.00235	CbGeAlD
Loperamide—Abdominal pain—Perindopril—coronary artery disease	9.68e-05	0.000981	CcSEcCtD
Loperamide—Diarrhoea—Olmesartan—coronary artery disease	9.67e-05	0.00098	CcSEcCtD
Loperamide—Headache—Eplerenone—coronary artery disease	9.67e-05	0.00098	CcSEcCtD
Loperamide—Nervous system disorder—Ramipril—coronary artery disease	9.66e-05	0.000979	CcSEcCtD
Loperamide—Anaphylactic shock—Timolol—coronary artery disease	9.63e-05	0.000976	CcSEcCtD
Loperamide—Pruritus—Pravastatin—coronary artery disease	9.62e-05	0.000975	CcSEcCtD
Loperamide—Loss of consciousness—Lisinopril—coronary artery disease	9.62e-05	0.000975	CcSEcCtD
Loperamide—Nausea—Clopidogrel—coronary artery disease	9.61e-05	0.000974	CcSEcCtD
Loperamide—Skin disorder—Ramipril—coronary artery disease	9.57e-05	0.00097	CcSEcCtD
Loperamide—Vomiting—Simvastatin—coronary artery disease	9.56e-05	0.000969	CcSEcCtD
Loperamide—Hypersensitivity—Telmisartan—coronary artery disease	9.56e-05	0.000969	CcSEcCtD
Loperamide—Nausea—Lovastatin—coronary artery disease	9.55e-05	0.000968	CcSEcCtD
Loperamide—Rash—Simvastatin—coronary artery disease	9.48e-05	0.000961	CcSEcCtD
Loperamide—Dermatitis—Simvastatin—coronary artery disease	9.47e-05	0.00096	CcSEcCtD
Loperamide—Asthenia—Trandolapril—coronary artery disease	9.47e-05	0.00096	CcSEcCtD
Loperamide—Urticaria—Furosemide—coronary artery disease	9.46e-05	0.000959	CcSEcCtD
Loperamide—Tamoxifen—ESR2—coronary artery disease	9.46e-05	0.053	CrCbGaD
Loperamide—Diarrhoea—Niacin—coronary artery disease	9.45e-05	0.000958	CcSEcCtD
Loperamide—Nervous system disorder—Timolol—coronary artery disease	9.44e-05	0.000957	CcSEcCtD
Loperamide—Asthenia—Enalapril—coronary artery disease	9.44e-05	0.000956	CcSEcCtD
Loperamide—Headache—Simvastatin—coronary artery disease	9.42e-05	0.000955	CcSEcCtD
Loperamide—Abdominal pain—Furosemide—coronary artery disease	9.41e-05	0.000954	CcSEcCtD
Loperamide—Gastrointestinal pain—Losartan—coronary artery disease	9.39e-05	0.000952	CcSEcCtD
Loperamide—Dizziness—Valsartan—coronary artery disease	9.39e-05	0.000952	CcSEcCtD
Loperamide—Nausea—Ezetimibe—coronary artery disease	9.37e-05	0.000949	CcSEcCtD
Loperamide—Skin disorder—Timolol—coronary artery disease	9.35e-05	0.000948	CcSEcCtD
Loperamide—Dizziness—Olmesartan—coronary artery disease	9.35e-05	0.000947	CcSEcCtD
Loperamide—Pruritus—Trandolapril—coronary artery disease	9.34e-05	0.000947	CcSEcCtD
Loperamide—Asthenia—Telmisartan—coronary artery disease	9.31e-05	0.000943	CcSEcCtD
Loperamide—Pruritus—Enalapril—coronary artery disease	9.3e-05	0.000943	CcSEcCtD
Loperamide—Diarrhoea—Pravastatin—coronary artery disease	9.3e-05	0.000943	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	9.25e-05	0.000938	CcSEcCtD
Loperamide—Discomfort—Lisinopril—coronary artery disease	9.21e-05	0.000933	CcSEcCtD
Loperamide—Pruritus—Telmisartan—coronary artery disease	9.18e-05	0.00093	CcSEcCtD
Loperamide—Nausea—Eplerenone—coronary artery disease	9.17e-05	0.000929	CcSEcCtD
Loperamide—Dizziness—Niacin—coronary artery disease	9.13e-05	0.000926	CcSEcCtD
Loperamide—Urticaria—Losartan—coronary artery disease	9.13e-05	0.000925	CcSEcCtD
Loperamide—Dry mouth—Lisinopril—coronary artery disease	9.11e-05	0.000924	CcSEcCtD
Loperamide—Abdominal pain—Losartan—coronary artery disease	9.08e-05	0.00092	CcSEcCtD
Loperamide—Asthenia—Captopril—coronary artery disease	9.05e-05	0.000917	CcSEcCtD
Loperamide—Diarrhoea—Trandolapril—coronary artery disease	9.03e-05	0.000916	CcSEcCtD
Loperamide—Vomiting—Valsartan—coronary artery disease	9.03e-05	0.000915	CcSEcCtD
Loperamide—Diarrhoea—Enalapril—coronary artery disease	9e-05	0.000912	CcSEcCtD
Loperamide—Dizziness—Pravastatin—coronary artery disease	8.99e-05	0.000911	CcSEcCtD
Loperamide—Vomiting—Olmesartan—coronary artery disease	8.99e-05	0.000911	CcSEcCtD
Loperamide—Rash—Valsartan—coronary artery disease	8.96e-05	0.000908	CcSEcCtD
Loperamide—Dermatitis—Valsartan—coronary artery disease	8.95e-05	0.000907	CcSEcCtD
Loperamide—Nausea—Simvastatin—coronary artery disease	8.93e-05	0.000905	CcSEcCtD
Loperamide—Anaphylactic shock—Lisinopril—coronary artery disease	8.93e-05	0.000905	CcSEcCtD
Loperamide—Pruritus—Captopril—coronary artery disease	8.92e-05	0.000904	CcSEcCtD
Loperamide—Rash—Olmesartan—coronary artery disease	8.91e-05	0.000903	CcSEcCtD
Loperamide—Dermatitis—Olmesartan—coronary artery disease	8.9e-05	0.000902	CcSEcCtD
Loperamide—Headache—Valsartan—coronary artery disease	8.9e-05	0.000902	CcSEcCtD
Loperamide—Diarrhoea—Telmisartan—coronary artery disease	8.87e-05	0.0009	CcSEcCtD
Loperamide—Headache—Olmesartan—coronary artery disease	8.85e-05	0.000897	CcSEcCtD
Loperamide—Asthenia—Perindopril—coronary artery disease	8.79e-05	0.000891	CcSEcCtD
Loperamide—Vomiting—Niacin—coronary artery disease	8.78e-05	0.00089	CcSEcCtD
Loperamide—Hypersensitivity—Furosemide—coronary artery disease	8.77e-05	0.000889	CcSEcCtD
Loperamide—Somnolence—Ramipril—coronary artery disease	8.76e-05	0.000887	CcSEcCtD
Loperamide—Dizziness—Trandolapril—coronary artery disease	8.73e-05	0.000885	CcSEcCtD
Loperamide—Rash—Niacin—coronary artery disease	8.71e-05	0.000883	CcSEcCtD
Loperamide—Dermatitis—Niacin—coronary artery disease	8.7e-05	0.000882	CcSEcCtD
Loperamide—Dizziness—Enalapril—coronary artery disease	8.7e-05	0.000881	CcSEcCtD
Loperamide—Skin disorder—Lisinopril—coronary artery disease	8.68e-05	0.000879	CcSEcCtD
Loperamide—Dyspepsia—Ramipril—coronary artery disease	8.67e-05	0.000879	CcSEcCtD
Loperamide—Pruritus—Perindopril—coronary artery disease	8.66e-05	0.000878	CcSEcCtD
Loperamide—Headache—Niacin—coronary artery disease	8.65e-05	0.000877	CcSEcCtD
Loperamide—Vomiting—Pravastatin—coronary artery disease	8.65e-05	0.000876	CcSEcCtD
Loperamide—Diarrhoea—Captopril—coronary artery disease	8.63e-05	0.000875	CcSEcCtD
Loperamide—Dizziness—Telmisartan—coronary artery disease	8.58e-05	0.000869	CcSEcCtD
Loperamide—Rash—Pravastatin—coronary artery disease	8.57e-05	0.000869	CcSEcCtD
Loperamide—Dermatitis—Pravastatin—coronary artery disease	8.57e-05	0.000868	CcSEcCtD
Loperamide—Somnolence—Timolol—coronary artery disease	8.56e-05	0.000868	CcSEcCtD
Loperamide—Asthenia—Furosemide—coronary artery disease	8.54e-05	0.000866	CcSEcCtD
Loperamide—Headache—Pravastatin—coronary artery disease	8.52e-05	0.000863	CcSEcCtD
Loperamide—Gastrointestinal disorder—Ramipril—coronary artery disease	8.5e-05	0.000862	CcSEcCtD
Loperamide—Fatigue—Ramipril—coronary artery disease	8.49e-05	0.000861	CcSEcCtD
Loperamide—Dyspepsia—Timolol—coronary artery disease	8.48e-05	0.000859	CcSEcCtD
Loperamide—Hypersensitivity—Losartan—coronary artery disease	8.46e-05	0.000858	CcSEcCtD
Loperamide—Nausea—Valsartan—coronary artery disease	8.44e-05	0.000855	CcSEcCtD
Loperamide—Pruritus—Furosemide—coronary artery disease	8.42e-05	0.000854	CcSEcCtD
Loperamide—Constipation—Ramipril—coronary artery disease	8.42e-05	0.000854	CcSEcCtD
Loperamide—Nausea—Olmesartan—coronary artery disease	8.4e-05	0.000851	CcSEcCtD
Loperamide—Vomiting—Trandolapril—coronary artery disease	8.4e-05	0.000851	CcSEcCtD
Loperamide—Diarrhoea—Perindopril—coronary artery disease	8.38e-05	0.000849	CcSEcCtD
Loperamide—Vomiting—Enalapril—coronary artery disease	8.36e-05	0.000848	CcSEcCtD
Loperamide—Dizziness—Captopril—coronary artery disease	8.34e-05	0.000845	CcSEcCtD
Loperamide—Rash—Trandolapril—coronary artery disease	8.33e-05	0.000844	CcSEcCtD
Loperamide—Dermatitis—Trandolapril—coronary artery disease	8.32e-05	0.000843	CcSEcCtD
Loperamide—Gastrointestinal disorder—Timolol—coronary artery disease	8.31e-05	0.000843	CcSEcCtD
Loperamide—Fatigue—Timolol—coronary artery disease	8.3e-05	0.000841	CcSEcCtD
Loperamide—Rash—Enalapril—coronary artery disease	8.29e-05	0.00084	CcSEcCtD
Loperamide—Dermatitis—Enalapril—coronary artery disease	8.28e-05	0.00084	CcSEcCtD
Loperamide—Headache—Trandolapril—coronary artery disease	8.27e-05	0.000838	CcSEcCtD
Loperamide—Vomiting—Telmisartan—coronary artery disease	8.25e-05	0.000836	CcSEcCtD
Loperamide—Asthenia—Losartan—coronary artery disease	8.24e-05	0.000835	CcSEcCtD
Loperamide—Headache—Enalapril—coronary artery disease	8.24e-05	0.000835	CcSEcCtD
Loperamide—Nausea—Niacin—coronary artery disease	8.2e-05	0.000831	CcSEcCtD
Loperamide—Rash—Telmisartan—coronary artery disease	8.18e-05	0.000829	CcSEcCtD
Loperamide—Dermatitis—Telmisartan—coronary artery disease	8.17e-05	0.000828	CcSEcCtD
Loperamide—Diarrhoea—Furosemide—coronary artery disease	8.15e-05	0.000826	CcSEcCtD
Loperamide—Pruritus—Losartan—coronary artery disease	8.13e-05	0.000824	CcSEcCtD
Loperamide—Headache—Telmisartan—coronary artery disease	8.13e-05	0.000824	CcSEcCtD
Loperamide—Dizziness—Perindopril—coronary artery disease	8.1e-05	0.000821	CcSEcCtD
Loperamide—Nausea—Pravastatin—coronary artery disease	8.08e-05	0.000819	CcSEcCtD
Loperamide—Gastrointestinal pain—Ramipril—coronary artery disease	8.05e-05	0.000816	CcSEcCtD
Loperamide—Vomiting—Captopril—coronary artery disease	8.02e-05	0.000813	CcSEcCtD
Loperamide—Rash—Captopril—coronary artery disease	7.95e-05	0.000806	CcSEcCtD
Loperamide—Dermatitis—Captopril—coronary artery disease	7.95e-05	0.000805	CcSEcCtD
Loperamide—Somnolence—Lisinopril—coronary artery disease	7.94e-05	0.000805	CcSEcCtD
Loperamide—Clotrimazole—CYP2C19—coronary artery disease	7.91e-05	0.0443	CrCbGaD
Loperamide—Headache—Captopril—coronary artery disease	7.9e-05	0.000801	CcSEcCtD
Loperamide—Gastrointestinal pain—Timolol—coronary artery disease	7.87e-05	0.000798	CcSEcCtD
Loperamide—Dizziness—Furosemide—coronary artery disease	7.87e-05	0.000798	CcSEcCtD
Loperamide—Dyspepsia—Lisinopril—coronary artery disease	7.86e-05	0.000797	CcSEcCtD
Loperamide—Diarrhoea—Losartan—coronary artery disease	7.86e-05	0.000797	CcSEcCtD
Loperamide—Nausea—Trandolapril—coronary artery disease	7.84e-05	0.000795	CcSEcCtD
Loperamide—Urticaria—Ramipril—coronary artery disease	7.82e-05	0.000793	CcSEcCtD
Loperamide—Nausea—Enalapril—coronary artery disease	7.81e-05	0.000792	CcSEcCtD
Loperamide—Vomiting—Perindopril—coronary artery disease	7.79e-05	0.000789	CcSEcCtD
Loperamide—Abdominal pain—Ramipril—coronary artery disease	7.79e-05	0.000789	CcSEcCtD
Loperamide—Rash—Perindopril—coronary artery disease	7.72e-05	0.000783	CcSEcCtD
Loperamide—Dermatitis—Perindopril—coronary artery disease	7.71e-05	0.000782	CcSEcCtD
Loperamide—Gastrointestinal disorder—Lisinopril—coronary artery disease	7.71e-05	0.000782	CcSEcCtD
Loperamide—Nausea—Telmisartan—coronary artery disease	7.7e-05	0.000781	CcSEcCtD
Loperamide—Fatigue—Lisinopril—coronary artery disease	7.7e-05	0.000781	CcSEcCtD
Loperamide—Headache—Perindopril—coronary artery disease	7.67e-05	0.000778	CcSEcCtD
Loperamide—Urticaria—Timolol—coronary artery disease	7.65e-05	0.000775	CcSEcCtD
Loperamide—Constipation—Lisinopril—coronary artery disease	7.64e-05	0.000774	CcSEcCtD
Loperamide—Abdominal pain—Timolol—coronary artery disease	7.61e-05	0.000772	CcSEcCtD
Loperamide—Dizziness—Losartan—coronary artery disease	7.6e-05	0.00077	CcSEcCtD
Loperamide—Vomiting—Furosemide—coronary artery disease	7.57e-05	0.000767	CcSEcCtD
Loperamide—Rash—Furosemide—coronary artery disease	7.51e-05	0.000761	CcSEcCtD
Loperamide—Dermatitis—Furosemide—coronary artery disease	7.5e-05	0.00076	CcSEcCtD
Loperamide—Nausea—Captopril—coronary artery disease	7.49e-05	0.000759	CcSEcCtD
Loperamide—Headache—Furosemide—coronary artery disease	7.46e-05	0.000756	CcSEcCtD
Loperamide—Gastrointestinal pain—Lisinopril—coronary artery disease	7.3e-05	0.00074	CcSEcCtD
Loperamide—Vomiting—Losartan—coronary artery disease	7.3e-05	0.00074	CcSEcCtD
Loperamide—Nausea—Perindopril—coronary artery disease	7.27e-05	0.000737	CcSEcCtD
Loperamide—Hypersensitivity—Ramipril—coronary artery disease	7.26e-05	0.000736	CcSEcCtD
Loperamide—Rash—Losartan—coronary artery disease	7.24e-05	0.000734	CcSEcCtD
Loperamide—Dermatitis—Losartan—coronary artery disease	7.24e-05	0.000733	CcSEcCtD
Loperamide—Headache—Losartan—coronary artery disease	7.2e-05	0.000729	CcSEcCtD
Loperamide—Haloperidol—CYP2C19—coronary artery disease	7.12e-05	0.0399	CrCbGaD
Loperamide—Urticaria—Lisinopril—coronary artery disease	7.1e-05	0.000719	CcSEcCtD
Loperamide—Hypersensitivity—Timolol—coronary artery disease	7.09e-05	0.000719	CcSEcCtD
Loperamide—Nausea—Furosemide—coronary artery disease	7.07e-05	0.000717	CcSEcCtD
Loperamide—Asthenia—Ramipril—coronary artery disease	7.07e-05	0.000716	CcSEcCtD
Loperamide—Abdominal pain—Lisinopril—coronary artery disease	7.06e-05	0.000716	CcSEcCtD
Loperamide—Pruritus—Ramipril—coronary artery disease	6.97e-05	0.000706	CcSEcCtD
Loperamide—Asthenia—Timolol—coronary artery disease	6.91e-05	0.0007	CcSEcCtD
Loperamide—Nausea—Losartan—coronary artery disease	6.82e-05	0.000692	CcSEcCtD
Loperamide—Pruritus—Timolol—coronary artery disease	6.81e-05	0.00069	CcSEcCtD
Loperamide—Diarrhoea—Ramipril—coronary artery disease	6.74e-05	0.000683	CcSEcCtD
Loperamide—Diarrhoea—Timolol—coronary artery disease	6.59e-05	0.000668	CcSEcCtD
Loperamide—Hypersensitivity—Lisinopril—coronary artery disease	6.58e-05	0.000667	CcSEcCtD
Loperamide—Dizziness—Ramipril—coronary artery disease	6.51e-05	0.00066	CcSEcCtD
Loperamide—Asthenia—Lisinopril—coronary artery disease	6.41e-05	0.00065	CcSEcCtD
Loperamide—Dizziness—Timolol—coronary artery disease	6.37e-05	0.000645	CcSEcCtD
Loperamide—Pruritus—Lisinopril—coronary artery disease	6.32e-05	0.000641	CcSEcCtD
Loperamide—Vomiting—Ramipril—coronary artery disease	6.26e-05	0.000635	CcSEcCtD
Loperamide—Rash—Ramipril—coronary artery disease	6.21e-05	0.000629	CcSEcCtD
Loperamide—Dermatitis—Ramipril—coronary artery disease	6.2e-05	0.000629	CcSEcCtD
Loperamide—Headache—Ramipril—coronary artery disease	6.17e-05	0.000625	CcSEcCtD
Loperamide—Vomiting—Timolol—coronary artery disease	6.12e-05	0.000621	CcSEcCtD
Loperamide—Diarrhoea—Lisinopril—coronary artery disease	6.11e-05	0.000619	CcSEcCtD
Loperamide—Rash—Timolol—coronary artery disease	6.07e-05	0.000615	CcSEcCtD
Loperamide—Dermatitis—Timolol—coronary artery disease	6.07e-05	0.000615	CcSEcCtD
Loperamide—Headache—Timolol—coronary artery disease	6.03e-05	0.000611	CcSEcCtD
Loperamide—Dizziness—Lisinopril—coronary artery disease	5.91e-05	0.000599	CcSEcCtD
Loperamide—Nausea—Ramipril—coronary artery disease	5.85e-05	0.000593	CcSEcCtD
Loperamide—Tamoxifen—ESR1—coronary artery disease	5.83e-05	0.0326	CrCbGaD
Loperamide—Haloperidol—HTR2A—coronary artery disease	5.77e-05	0.0323	CrCbGaD
Loperamide—Nausea—Timolol—coronary artery disease	5.72e-05	0.00058	CcSEcCtD
Loperamide—Vomiting—Lisinopril—coronary artery disease	5.68e-05	0.000576	CcSEcCtD
Loperamide—Rash—Lisinopril—coronary artery disease	5.63e-05	0.000571	CcSEcCtD
Loperamide—Dermatitis—Lisinopril—coronary artery disease	5.63e-05	0.00057	CcSEcCtD
Loperamide—Headache—Lisinopril—coronary artery disease	5.6e-05	0.000567	CcSEcCtD
Loperamide—Nausea—Lisinopril—coronary artery disease	5.31e-05	0.000538	CcSEcCtD
Loperamide—Tamoxifen—CYP2C19—coronary artery disease	4.68e-05	0.0262	CrCbGaD
Loperamide—Methadone—CYP2C19—coronary artery disease	4.64e-05	0.026	CrCbGaD
Loperamide—CALM2—Metabolism—POMC—coronary artery disease	1.02e-06	8.72e-06	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—IL6—coronary artery disease	1.02e-06	8.7e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HIF1A—coronary artery disease	1.02e-06	8.69e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HIF1A—coronary artery disease	1.02e-06	8.69e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—APOA1—coronary artery disease	1.02e-06	8.67e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—AGT—coronary artery disease	1.02e-06	8.66e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—AGT—coronary artery disease	1.02e-06	8.66e-06	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL1B—coronary artery disease	1.02e-06	8.65e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.01e-06	8.64e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.01e-06	8.63e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.01e-06	8.63e-06	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—AKT1—coronary artery disease	1.01e-06	8.62e-06	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—AKT1—coronary artery disease	1.01e-06	8.62e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—KDR—coronary artery disease	1.01e-06	8.59e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—PTGS2—coronary artery disease	1.01e-06	8.58e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—MTHFR—coronary artery disease	1e-06	8.54e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MAPK14—coronary artery disease	1e-06	8.54e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MMP9—coronary artery disease	1e-06	8.52e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CD36—coronary artery disease	9.97e-07	8.49e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—LEP—coronary artery disease	9.96e-07	8.49e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—APOE—coronary artery disease	9.96e-07	8.49e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—APOE—coronary artery disease	9.96e-07	8.49e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—LEP—coronary artery disease	9.96e-07	8.49e-06	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—ALB—coronary artery disease	9.91e-07	8.44e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CTGF—coronary artery disease	9.9e-07	8.43e-06	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—IL6—coronary artery disease	9.88e-07	8.41e-06	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—IL6—coronary artery disease	9.88e-07	8.41e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—APOA1—coronary artery disease	9.85e-07	8.39e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—APOA1—coronary artery disease	9.85e-07	8.39e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PPP2CA—coronary artery disease	9.85e-07	8.39e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—ESR1—coronary artery disease	9.83e-07	8.38e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL1B—coronary artery disease	9.82e-07	8.37e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL1B—coronary artery disease	9.82e-07	8.37e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GOT2—coronary artery disease	9.81e-07	8.36e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—HMGCR—coronary artery disease	9.81e-07	8.36e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—KDR—coronary artery disease	9.76e-07	8.31e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—KDR—coronary artery disease	9.76e-07	8.31e-06	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TGFB1—coronary artery disease	9.75e-07	8.31e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—PTGS2—coronary artery disease	9.75e-07	8.3e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—PTGS2—coronary artery disease	9.75e-07	8.3e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—F2—coronary artery disease	9.71e-07	8.27e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—FN1—coronary artery disease	9.71e-07	8.27e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—AKT1—coronary artery disease	9.7e-07	8.26e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MAPK14—coronary artery disease	9.7e-07	8.26e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MAPK14—coronary artery disease	9.7e-07	8.26e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL6ST—coronary artery disease	9.67e-07	8.24e-06	CbGpPWpGaD
Loperamide—CALM3—Metabolism—ALB—coronary artery disease	9.65e-07	8.22e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NFKBIA—coronary artery disease	9.6e-07	8.17e-06	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—MAPK1—coronary artery disease	9.56e-07	8.15e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—AGT—coronary artery disease	9.53e-07	8.11e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—ESR1—coronary artery disease	9.51e-07	8.1e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—ESR1—coronary artery disease	9.51e-07	8.1e-06	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—NOS3—coronary artery disease	9.48e-07	8.08e-06	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—PIK3CA—coronary artery disease	9.47e-07	8.06e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—MTHFR—coronary artery disease	9.45e-07	8.05e-06	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—AKT1—coronary artery disease	9.42e-07	8.02e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—F2—coronary artery disease	9.4e-07	8e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—F2—coronary artery disease	9.4e-07	8e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—FN1—coronary artery disease	9.4e-07	8e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—FN1—coronary artery disease	9.4e-07	8e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL6ST—coronary artery disease	9.36e-07	7.97e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL6ST—coronary artery disease	9.36e-07	7.97e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—APOE—coronary artery disease	9.34e-07	7.95e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PPARG—coronary artery disease	9.33e-07	7.95e-06	CbGpPWpGaD
Loperamide—CALM1—Metabolism—ALB—coronary artery disease	9.33e-07	7.95e-06	CbGpPWpGaD
Loperamide—CALM2—Metabolism—ALB—coronary artery disease	9.33e-07	7.95e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—KIT—coronary artery disease	9.3e-07	7.92e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NFKBIA—coronary artery disease	9.28e-07	7.91e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NFKBIA—coronary artery disease	9.28e-07	7.91e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—APOA1—coronary artery disease	9.23e-07	7.86e-06	CbGpPWpGaD
Loperamide—CALM3—Metabolism—NOS3—coronary artery disease	9.23e-07	7.86e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—POMC—coronary artery disease	9.21e-07	7.84e-06	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—AKT1—coronary artery disease	9.11e-07	7.76e-06	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—AKT1—coronary artery disease	9.11e-07	7.76e-06	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—AKT1—coronary artery disease	9.05e-07	7.7e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PLCB1—coronary artery disease	9.02e-07	7.68e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—KIT—coronary artery disease	8.99e-07	7.66e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—KIT—coronary artery disease	8.99e-07	7.66e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—VEGFA—coronary artery disease	8.98e-07	7.65e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—AGT—coronary artery disease	8.98e-07	7.65e-06	CbGpPWpGaD
Loperamide—CALM2—Metabolism—NOS3—coronary artery disease	8.93e-07	7.6e-06	CbGpPWpGaD
Loperamide—CALM1—Metabolism—NOS3—coronary artery disease	8.93e-07	7.6e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—GSK3B—coronary artery disease	8.92e-07	7.6e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—POMC—coronary artery disease	8.85e-07	7.54e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CREB1—coronary artery disease	8.85e-07	7.54e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—APOE—coronary artery disease	8.8e-07	7.49e-06	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—AKT1—coronary artery disease	8.75e-07	7.45e-06	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—AKT1—coronary artery disease	8.75e-07	7.45e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ABCA1—coronary artery disease	8.74e-07	7.45e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—APOA1—coronary artery disease	8.7e-07	7.41e-06	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PTGS2—coronary artery disease	8.67e-07	7.39e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CCL2—coronary artery disease	8.66e-07	7.37e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL6R—coronary artery disease	8.63e-07	7.35e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—GSK3B—coronary artery disease	8.63e-07	7.35e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—GSK3B—coronary artery disease	8.63e-07	7.35e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—POMC—coronary artery disease	8.56e-07	7.29e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—POMC—coronary artery disease	8.56e-07	7.29e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CREB1—coronary artery disease	8.56e-07	7.29e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CREB1—coronary artery disease	8.56e-07	7.29e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IGF1—coronary artery disease	8.51e-07	7.25e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—MAPK1—coronary artery disease	8.47e-07	7.21e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GGT1—coronary artery disease	8.47e-07	7.21e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GOT1—coronary artery disease	8.47e-07	7.21e-06	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PTGS2—coronary artery disease	8.44e-07	7.19e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—ALB—coronary artery disease	8.39e-07	7.15e-06	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—IL6—coronary artery disease	8.38e-07	7.14e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CCL2—coronary artery disease	8.37e-07	7.13e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CCL2—coronary artery disease	8.37e-07	7.13e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL6R—coronary artery disease	8.35e-07	7.11e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL6R—coronary artery disease	8.35e-07	7.11e-06	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—PIK3CA—coronary artery disease	8.3e-07	7.07e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TGFB1—coronary artery disease	8.24e-07	7.02e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IGF1—coronary artery disease	8.23e-07	7.01e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IGF1—coronary artery disease	8.23e-07	7.01e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—MAPK1—coronary artery disease	8.19e-07	6.98e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—MAPK1—coronary artery disease	8.19e-07	6.98e-06	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PTGS2—coronary artery disease	8.16e-07	6.95e-06	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PTGS2—coronary artery disease	8.16e-07	6.95e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PPARG—coronary artery disease	8.13e-07	6.93e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MAPK1—coronary artery disease	8.08e-07	6.88e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—SERPINE1—coronary artery disease	8.08e-07	6.88e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—NOS3—coronary artery disease	8.03e-07	6.84e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—POMC—coronary artery disease	8.02e-07	6.83e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—FGF2—coronary artery disease	7.82e-07	6.66e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—SERPINE1—coronary artery disease	7.82e-07	6.66e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—SERPINE1—coronary artery disease	7.82e-07	6.66e-06	CbGpPWpGaD
Loperamide—CALM3—Immune System—MAPK1—coronary artery disease	7.74e-07	6.59e-06	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—AKT1—coronary artery disease	7.73e-07	6.59e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NOS3—coronary artery disease	7.72e-07	6.57e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PPARG—coronary artery disease	7.66e-07	6.53e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GSTP1—coronary artery disease	7.61e-07	6.48e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—FGF2—coronary artery disease	7.57e-07	6.45e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—FGF2—coronary artery disease	7.57e-07	6.45e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—POMC—coronary artery disease	7.56e-07	6.44e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	7.54e-07	6.42e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—HMOX1—coronary artery disease	7.5e-07	6.39e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—JAK2—coronary artery disease	7.5e-07	6.39e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—MAPK1—coronary artery disease	7.49e-07	6.38e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—MAPK1—coronary artery disease	7.49e-07	6.38e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NOS3—coronary artery disease	7.46e-07	6.36e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NOS3—coronary artery disease	7.46e-07	6.36e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CAT—coronary artery disease	7.4e-07	6.3e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—PIK3CA—coronary artery disease	7.35e-07	6.26e-06	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—IL6—coronary artery disease	7.35e-07	6.26e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PTGS2—coronary artery disease	7.34e-07	6.25e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—ALB—coronary artery disease	7.31e-07	6.23e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—TGFB1—coronary artery disease	7.29e-07	6.21e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—JAK2—coronary artery disease	7.25e-07	6.18e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—JAK2—coronary artery disease	7.25e-07	6.18e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—APOB—coronary artery disease	7.19e-07	6.12e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—MAPK1—coronary artery disease	7.15e-07	6.09e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—PIK3CA—coronary artery disease	7.11e-07	6.06e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—PIK3CA—coronary artery disease	7.11e-07	6.06e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—TGFB1—coronary artery disease	7.05e-07	6e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—TGFB1—coronary artery disease	7.05e-07	6e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—PIK3CA—coronary artery disease	7.01e-07	5.97e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—NOS3—coronary artery disease	6.99e-07	5.96e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GSTM1—coronary artery disease	6.99e-07	5.95e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—MAPK1—coronary artery disease	6.91e-07	5.89e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—MAPK1—coronary artery disease	6.91e-07	5.89e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—ALB—coronary artery disease	6.89e-07	5.87e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—LPL—coronary artery disease	6.86e-07	5.84e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CXCL8—coronary artery disease	6.84e-07	5.83e-06	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—AKT1—coronary artery disease	6.78e-07	5.77e-06	CbGpPWpGaD
Loperamide—CALM3—Immune System—PIK3CA—coronary artery disease	6.72e-07	5.72e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GPX1—coronary artery disease	6.69e-07	5.7e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CXCL8—coronary artery disease	6.62e-07	5.64e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CXCL8—coronary artery disease	6.62e-07	5.64e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—NOS3—coronary artery disease	6.59e-07	5.61e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CASP3—coronary artery disease	6.55e-07	5.58e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CD36—coronary artery disease	6.52e-07	5.55e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—IL6—coronary artery disease	6.51e-07	5.54e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—PIK3CA—coronary artery disease	6.5e-07	5.53e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—PIK3CA—coronary artery disease	6.5e-07	5.53e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PPP2CA—coronary artery disease	6.44e-07	5.48e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PTGS2—coronary artery disease	6.4e-07	5.45e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CCND1—coronary artery disease	6.38e-07	5.43e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CASP3—coronary artery disease	6.34e-07	5.4e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CASP3—coronary artery disease	6.34e-07	5.4e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—IL6—coronary artery disease	6.3e-07	5.36e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—IL6—coronary artery disease	6.3e-07	5.36e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IL6—coronary artery disease	6.21e-07	5.29e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—PIK3CA—coronary artery disease	6.2e-07	5.28e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MMP9—coronary artery disease	6.19e-07	5.27e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—MTHFR—coronary artery disease	6.18e-07	5.26e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CCND1—coronary artery disease	6.17e-07	5.25e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CCND1—coronary artery disease	6.17e-07	5.25e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PTGS2—coronary artery disease	6.03e-07	5.13e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—AKT1—coronary artery disease	6e-07	5.11e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—PIK3CA—coronary artery disease	6e-07	5.11e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—PIK3CA—coronary artery disease	6e-07	5.11e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MMP9—coronary artery disease	5.99e-07	5.1e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MMP9—coronary artery disease	5.99e-07	5.1e-06	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL6—coronary artery disease	5.95e-07	5.06e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—AGT—coronary artery disease	5.87e-07	5e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—AKT1—coronary artery disease	5.81e-07	4.95e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—AKT1—coronary artery disease	5.81e-07	4.95e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL6—coronary artery disease	5.75e-07	4.9e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL6—coronary artery disease	5.75e-07	4.9e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—APOE—coronary artery disease	5.75e-07	4.9e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—AKT1—coronary artery disease	5.73e-07	4.88e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—APOA1—coronary artery disease	5.69e-07	4.84e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—VEGFA—coronary artery disease	5.56e-07	4.73e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—IL6—coronary artery disease	5.49e-07	4.68e-06	CbGpPWpGaD
Loperamide—CALM3—Immune System—AKT1—coronary artery disease	5.49e-07	4.67e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—VEGFA—coronary artery disease	5.38e-07	4.58e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—VEGFA—coronary artery disease	5.38e-07	4.58e-06	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PIK3CA—coronary artery disease	5.34e-07	4.54e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—IL6—coronary artery disease	5.31e-07	4.52e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—IL6—coronary artery disease	5.31e-07	4.52e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—AKT1—coronary artery disease	5.31e-07	4.52e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—AKT1—coronary artery disease	5.31e-07	4.52e-06	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PIK3CA—coronary artery disease	5.19e-07	4.42e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TGFB1—coronary artery disease	5.1e-07	4.35e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—AKT1—coronary artery disease	5.07e-07	4.31e-06	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PIK3CA—coronary artery disease	5.02e-07	4.28e-06	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PIK3CA—coronary artery disease	5.02e-07	4.28e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PPARG—coronary artery disease	5.01e-07	4.27e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MAPK1—coronary artery disease	5e-07	4.26e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—POMC—coronary artery disease	4.94e-07	4.21e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TGFB1—coronary artery disease	4.94e-07	4.2e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TGFB1—coronary artery disease	4.94e-07	4.2e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—AKT1—coronary artery disease	4.9e-07	4.17e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—AKT1—coronary artery disease	4.9e-07	4.17e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MAPK1—coronary artery disease	4.84e-07	4.12e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MAPK1—coronary artery disease	4.84e-07	4.12e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PIK3CA—coronary artery disease	4.52e-07	3.85e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ALB—coronary artery disease	4.5e-07	3.84e-06	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—AKT1—coronary artery disease	4.36e-07	3.71e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PIK3CA—coronary artery disease	4.34e-07	3.7e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—NOS3—coronary artery disease	4.31e-07	3.67e-06	CbGpPWpGaD
Loperamide—CALM3—Metabolism—AKT1—coronary artery disease	4.24e-07	3.61e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PIK3CA—coronary artery disease	4.2e-07	3.58e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PIK3CA—coronary artery disease	4.2e-07	3.58e-06	CbGpPWpGaD
Loperamide—CALM2—Metabolism—AKT1—coronary artery disease	4.1e-07	3.49e-06	CbGpPWpGaD
Loperamide—CALM1—Metabolism—AKT1—coronary artery disease	4.1e-07	3.49e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PTGS2—coronary artery disease	3.94e-07	3.36e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PIK3CA—coronary artery disease	3.94e-07	3.35e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL6—coronary artery disease	3.84e-07	3.27e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL6—coronary artery disease	3.72e-07	3.17e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL6—coronary artery disease	3.72e-07	3.17e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PIK3CA—coronary artery disease	3.71e-07	3.16e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—AKT1—coronary artery disease	3.69e-07	3.14e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—AKT1—coronary artery disease	3.55e-07	3.02e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—AKT1—coronary artery disease	3.43e-07	2.92e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—AKT1—coronary artery disease	3.43e-07	2.92e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—AKT1—coronary artery disease	3.21e-07	2.74e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—AKT1—coronary artery disease	3.03e-07	2.58e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PIK3CA—coronary artery disease	2.42e-07	2.07e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—AKT1—coronary artery disease	1.98e-07	1.69e-06	CbGpPWpGaD
